Risky Treatments: Understanding Your Options

Managing Crohn’s Disease and related conditions often involves making critical decisions about medications and therapies. Some treatment options, while effective for symptom management, come with significant risks. At The Tommy Kid Foundation, we prioritize transparency and patient empowerment, helping you navigate these complex choices.

Certain biologics and immunosuppressants, frequently prescribed to manage Crohn’s symptoms, have been associated with an increased risk of developing Hepatosplenic T-cell Lymphoma (HSTCL), a rare but aggressive form of cancer. This risk is particularly pronounced in young adult males under combined therapies.

Common Medications of Concern (click the links to learn more):

• Biologic agents such as infliximab (Remicade) and adalimumab (Humira)
• Immunosuppressants like azathioprine (Imuran) and mercaptopurine (6-MP)

Understanding the long-term implications of treatment is crucial. While medications can improve quality of life, patients and caregivers must weigh these benefits against potential risks. Our mission is to ensure that every individual can make fully informed choices by offering accurate information and alternative treatment options.

In addition to conventional therapies, there are low-risk and holistic approaches that may complement or replace high-risk medications. These include dietary adjustments, probiotics, and emerging non-toxic therapies backed by ongoing research.

The Tommy Kid Foundation is dedicated to raising awareness about these risks and advocating for research into safer, more effective treatment methods. Together, we aim to create a healthcare environment where every patient feels empowered and supported.

OUR ADVICE: BE INFORMED BEFORE YOU MAKE YOUR DECISION ON YOUR TREATMENT.  KNOW THE RISKS AS TIME GOES ON AND PERSIST IN FINDING ALTERNATIVES TO THESE TREATMENTS.